English

Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to “Thank God I Got It” by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio

by

NAPLES, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), a leading entity in the music industry, is excited to announce the acquisition of the royalty rights to “Thank God I Got It” by the renowned artist Desiigner. This acquisition underscores Music Licensing, Inc.’s commitment to diversifying its portfolio with high-quality, revenue-generating […]

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

by

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to […]

“SCG – CPAC” and “Samsung E&A” sign MOU to bolster 3D printing technology and special cementitious materials in global market

by

BANGKOK, THAILAND – Media OutReach Newswire – 2 September 2024 – On behalf of CPAC, a cement and building materials company under Siam Cement Group (SCG), Mr. Thammasak Sethaudom, President & CEO of SCG (second from the left), and Mr. Surachai Nimlaor, President of SCG Cement and Green Solution Business (first from the left), signed the Memorandum of Understanding (MoU) with Mr. Hong […]

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

by

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end of 2024 U.S. commercial launch, expected at the beginning of 2025, fully funded with over €85 million in new capital […]

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV

by

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”). A class action lawsuit […]

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages STMicroelectronics N.V. to Secure Counsel Before Important Deadline in Securities Class Action – STM

by

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of securities of STMicroelectronics N.V. (NYSE: STM) between January 25, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already […]

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA

by

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has […]

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CXM

by

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) — WHY: New York, N.Y., September 1, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline. SO […]